Atropine sulfate injection (2015-06-23)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 6500580 | - Recalling Firm
- BioSyvent Pharma Inc.
- 170 Attwell Drive, Suite 520
- Toronto
- M9W 5Z5
- Ontario
- CANADA
- Marketing Authorization Holder
- BioSyvent Pharma Inc.
- 170 Attwell Drive, Suite 520
- Toronto
- M9W 5Z5
- Ontario
- CANADA
| B. Atropine sulfate injection 1 mg / 5 mL | Solution | DIN 02426277 | Atropine Sulfate 1 mg / 5 mL |
| 6500565 | - Recalling Firm
- BioSyvent Pharma Inc.
- 170 Attwell Drive, Suite 520
- Toronto
- M9W 5Z5
- Ontario
- CANADA
- Marketing Authorization Holder
- BioSyvent Pharma Inc.
- 170 Attwell Drive, Suite 520
- Toronto
- M9W 5Z5
- Ontario
- CANADA
| A. Atropine sulfate injection 0.5 mg / 5 mL | Solution | DIN 02426269 | Atropine Sulfate 0.5 mg / 5 mL |
Recalled Products
-
Atropine sulfate injection 0.5 mg / 5 mL
-
Atropine sulfate injection 1 mg / 5 mL
Inaccurate dosing information on inner and outer labels.
Wholesalers and Hospitals